[BGLC] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
31-May-2024
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 56.05%
YoY- -505.88%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 2,382 2,377 3,029 3,449 3,070 28 0 -
PBT -84 -53 31 339 -47 -60 272 -
Tax 20 16 14 0 1 1 0 -
NP -104 -69 17 339 1,070 -61 272 -
Tax Rate - - -45.59% 0.00% - - 0.00% -
Total Cost 2,486 2,446 3,012 3,110 2,000 90 -272 -
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -4.36 -2.91 0.56 9.82 34.84 -218.84 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.01 -0.00 0.00 0.02 0.12 -0.01 0.06 -
EPS Diluted -0.01 -0.00 0.00 0.02 0.12 -0.01 0.06 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.